Biotech

All Articles

Basilea scores $268M BARDA backing for antifungals, anti-biotics

.Basilea Pharmaceutica's job developing new antifungals has acquired a considerable boost coming fro...

Capricor offers Europe civil liberties to late-stage DMD treatment for $35M

.Possessing already gathered up the U.S. civil liberties to Capricor Therapeutics' late-stage Duchen...

FDA junks adcomm for Applied's unusual condition drug

.After dismissing the decision date for Applied Therapeutics' metabolic condition medicine govoresta...

Novo inks $600M NanoVation bargain to research hereditary drugs ex-liver

.Novo Nordisk is actually proceeding its push in to genetic medications, accepting pay NanoVation Th...

Innovent hyperlinks cytokine to colorectal cancer cells responses

.Innovent Biologics has created the case that its checkpoint inhibitor-cytokine blend healthy protei...

Merck, Daiichi ADC hits objective in phase 3 lung cancer cells study

.A period 3 trial of Daiichi Sankyo and Merck &amp Co.'s HER3-directed antibody-drug conjugate (ADC)...

Rakovina strengthens AI concentrate along with collab to select cancer cells aim ats

.5 months after Rakovina Rehabs rotated towards expert system, the cancer-focused biotech has joined...

Ascendis' dwarfism drug favorites in phase 3, intimidates BioMarin

.Ascendis Pharma has become a possible hazard to BioMarin's Voxzogo, reporting phase 3 growth condit...

Despite ph. 3 skip, Alkeus sees path ahead of time for eye disease asset

.Though Alkeus Pharmaceuticals' oral eye health condition resource stopped working to substantially ...

Kairos goes public with $6M IPO to fund tests of cancer cells medication

.Along with a trio of biotechs striking the Nasdaq on Friday, it was actually very easy to miss out ...